| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 1168 | 21 | 1096 | 113 | 1376 | 226 | 1376 |
| ERLYTX | 79 | 0 | 0 | 8 | 97 | 18 | 110 |
| GI | 181 | 6 | 313 | 18 | 219 | 31 | 189 |
| GU | 357 | 4 | 209 | 24 | 292 | 42 | 256 |
| LEUK | 150 | 4 | 209 | 14 | 170 | 34 | 207 |
| LUNG | 191 | 0 | 0 | 8 | 97 | 33 | 201 |
| LYMPH | 411 | 9 | 470 | 54 | 657 | 89 | 542 |
| MELAN | 137 | 0 | 0 | 0 | 0 | 0 | 0 |
| MMYEL | 111 | 2 | 104 | 10 | 122 | 23 | 140 |
| MMYL | 1 | 1 | 52 | 1 | 12 | 1 | 6 |
| MULT | 40 | 0 | 0 | 4 | 49 | 13 | 79 |
| OTHER | 53 | 0 | 0 | 3 | 37 | 10 | 61 |
| SXQOL | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2880 | 47 | 2453 | 257 | 3128 | 520 | 3167 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 2 | 2 | 104 | 2 | 24 | 2 | 12 | |
| CCD | 160 | 4 | 209 | 21 | 256 | 38 | 231 |
| ERLYTX | 10 | 0 | 0 | 1 | 12 | 3 | 18 |
| GU | 3 | 0 | 0 | 0 | 0 | 2 | 12 |
| LEUK | 632 | 7 | 365 | 55 | 670 | 109 | 664 |
| LUNG | 366 | 2 | 104 | 24 | 292 | 55 | 335 |
| OTHER | 34 | 0 | 0 | 3 | 37 | 5 | 30 |
| PEOLC | 108 | 0 | 0 | 0 | 0 | 1 | 6 |
| PREV | 223 | 5 | 261 | 24 | 292 | 47 | 286 |
| SXQOL | 614 | 14 | 730 | 66 | 804 | 129 | 785 |
| Total | 2152 | 34 | 1773 | 196 | 2387 | 391 | 2379 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 2 | 2 | 104 | 2 | 24 | 2 | 12 | |
| BREAST | 1168 | 21 | 1096 | 113 | 1376 | 226 | 1376 |
| CCD | 160 | 4 | 209 | 21 | 256 | 38 | 231 |
| ERLYTX | 89 | 0 | 0 | 9 | 110 | 21 | 128 |
| GI | 181 | 6 | 313 | 18 | 219 | 31 | 189 |
| GU | 360 | 4 | 209 | 24 | 292 | 44 | 268 |
| LEUK | 782 | 11 | 574 | 69 | 840 | 143 | 871 |
| LUNG | 557 | 2 | 104 | 32 | 390 | 88 | 536 |
| LYMPH | 411 | 9 | 470 | 54 | 657 | 89 | 542 |
| MELAN | 137 | 0 | 0 | 0 | 0 | 0 | 0 |
| MMYEL | 111 | 2 | 104 | 10 | 122 | 23 | 140 |
| MMYL | 1 | 1 | 52 | 1 | 12 | 1 | 6 |
| MULT | 40 | 0 | 0 | 4 | 49 | 13 | 79 |
| OTHER | 87 | 0 | 0 | 6 | 73 | 15 | 91 |
| PEOLC | 108 | 0 | 0 | 0 | 0 | 1 | 6 |
| PREV | 223 | 5 | 261 | 24 | 292 | 47 | 286 |
| SXQOL | 615 | 14 | 730 | 66 | 804 | 129 | 785 |
| Total | 5032 | 81 | 4226 | 453 | 5516 | 911 | 5546 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 740 | 15 | 783 | 69 | 840 | 136 | 828 |
| ERLYTX | 48 | 0 | 0 | 7 | 85 | 14 | 85 |
| GI | 131 | 4 | 209 | 14 | 170 | 25 | 152 |
| GU | 284 | 4 | 209 | 21 | 256 | 34 | 207 |
| LEUK | 96 | 3 | 157 | 8 | 97 | 22 | 134 |
| LUNG | 120 | 0 | 0 | 6 | 73 | 20 | 122 |
| LYMPH | 269 | 5 | 261 | 30 | 365 | 53 | 323 |
| MELAN | 91 | 0 | 0 | 0 | 0 | 0 | 0 |
| MMYEL | 65 | 0 | 0 | 3 | 37 | 11 | 67 |
| MMYL | 1 | 1 | 52 | 1 | 12 | 1 | 6 |
| MULT | 15 | 0 | 0 | 0 | 0 | 5 | 30 |
| OTHER | 53 | 0 | 0 | 3 | 37 | 10 | 61 |
| SXQOL | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1914 | 32 | 1671 | 162 | 1972 | 331 | 2015 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 2 | 2 | 104 | 2 | 24 | 2 | 12 | |
| CCD | 130 | 3 | 157 | 13 | 158 | 25 | 152 |
| ERLYTX | 10 | 0 | 0 | 1 | 12 | 3 | 18 |
| GU | 3 | 0 | 0 | 0 | 0 | 2 | 12 |
| LEUK | 267 | 1 | 52 | 18 | 219 | 42 | 256 |
| LUNG | 228 | 2 | 104 | 14 | 170 | 30 | 183 |
| OTHER | 34 | 0 | 0 | 3 | 37 | 5 | 30 |
| PEOLC | 78 | 0 | 0 | 0 | 0 | 1 | 6 |
| PREV | 222 | 4 | 209 | 23 | 280 | 46 | 280 |
| SXQOL | 443 | 9 | 470 | 46 | 560 | 96 | 584 |
| Total | 1417 | 21 | 1096 | 120 | 1460 | 252 | 1533 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 1 | 1 | 52 | 1 | 12 | 1 | 6 | |
| BREAST | 918 | 17 | 887 | 86 | 1047 | 164 | 998 |
| CCD | 165 | 2 | 104 | 16 | 195 | 38 | 231 |
| ERLYTX | 58 | 0 | 0 | 8 | 97 | 17 | 103 |
| GI | 134 | 2 | 104 | 12 | 146 | 25 | 152 |
| GU | 317 | 6 | 313 | 19 | 231 | 44 | 268 |
| LEUK | 364 | 4 | 209 | 26 | 317 | 64 | 390 |
| LUNG | 367 | 2 | 104 | 24 | 292 | 59 | 359 |
| LYMPH | 269 | 5 | 261 | 30 | 365 | 53 | 323 |
| MELAN | 91 | 0 | 0 | 0 | 0 | 0 | 0 |
| MMYEL | 65 | 0 | 0 | 3 | 37 | 11 | 67 |
| MMYL | 1 | 1 | 52 | 1 | 12 | 1 | 6 |
| MULT | 38 | 1 | 52 | 1 | 12 | 4 | 24 |
| OTHER | 220 | 0 | 0 | 6 | 73 | 24 | 146 |
| PEOLC | 75 | 0 | 0 | 1 | 12 | 1 | 6 |
| PREV | 222 | 4 | 209 | 23 | 280 | 46 | 280 |
| SXQOL | 444 | 9 | 470 | 46 | 560 | 96 | 584 |
| Total | 3749 | 54 | 2817 | 303 | 3688 | 648 | 3943 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 974 | 16 | 835 | 94 | 1144 | 199 | 1211 |
| ERLYTX | 74 | 0 | 0 | 8 | 97 | 15 | 91 |
| GI | 106 | 4 | 209 | 10 | 122 | 18 | 110 |
| GU | 235 | 3 | 157 | 21 | 256 | 34 | 207 |
| LEUK | 116 | 4 | 209 | 13 | 158 | 29 | 177 |
| LUNG | 161 | 0 | 0 | 7 | 85 | 31 | 189 |
| LYMPH | 341 | 8 | 417 | 50 | 609 | 77 | 469 |
| MMYEL | 98 | 2 | 104 | 9 | 110 | 21 | 128 |
| MULT | 40 | 0 | 0 | 4 | 49 | 13 | 79 |
| Total | 2145 | 37 | 1931 | 216 | 2630 | 437 | 2661 |
| Inst. | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| Member | 1964 | 33 | 1722 | 160 | 1948 | 339 | 2064 |
| AFFIL | 138 | 3 | 157 | 13 | 158 | 25 | 152 |
| CCOP/NCORP | 1229 | 17 | 887 | 109 | 1327 | 219 | 1333 |
| Non-SWOG | 1699 | 26 | 1357 | 169 | 2058 | 326 | 1985 |
| Total | 5030 | 79 | 4123 | 451 | 5491 | 909 | 5534 |
| ADMIN | STUDYID | STNAME | REGTYPE | Opened? | Open Date |
|---|---|---|---|---|---|
| GU | S2419 | Renal, adv clear cell, IO +/- Biotx, BIOFRONT | 1 | Y | 22-APR-26 |
| ADMIN | STUDYID | STNAME | REGTYPE | Opened? | Open Date |
|---|---|---|---|---|---|
| GU | NRGGU008 | Pros,Node+, Abiraterone acetate + Apalutamide | 1 | E | 15-APR-26 |
| BREAST | A012301 | Breast, Early Stg, Tamoxifen | 1 | E | 13-MAY-26 |
| LUNG | S1933 | NSCLC, Stg II-III, RT + Atezo | 2 | N | 01-MAY-26 |
| ADMIN | STUDYID | STNAME | REGTYPE | Registrations |
|---|---|---|---|---|
| BREAST | S2212 | Breast, TNBC, Neoadj Chemo + Pembro | 1 | 13 |
| LEUK | MYELOMATCH | MSRP for the NCI myeloMATCH Clinical Trials | 1 | 7 |
| SXQOL | S2013 | I-CHECKIT: ICI toxicity risk prediction study | 1 | 7 |
| SXQOL | S2205 | ICE COMPRESS: Reduction of CIPN from Taxanes | 1 | 7 |
| BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 1 | 7 |
| LYMPH | S2308 | FL, LTB, Mosunetuzumab vs Rituximab | 1 | 6 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 2 | 5 |
| PREV | NRGCC005 | Colon,Non-AdvancedAdenomas,Colonoscopy5v10yrs | 1 | 4 |
| BREAST | A012301 | Breast, Early Stg, Tamoxifen | 1 | 3 |
| LEUK | MM1OA-S03 | AML, Newly Dx, Ven+ASTX727 vs Ven+ASTX727+Ena | 1 | 3 |
| BREAST | NRGBR009 | Breast, EarlyStg, Adjuvant Chemo | 1 | 3 |
| GU | S1931 | RENAL, Stg IV, IO + Nephrectomy. vs IO Only | 1 | 3 |
| GI | S2104 | Panc,Resect High-risk,Postop Adj Chemo vs Obs | 1 | 3 |
| BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 2 | 3 |
| CCD | S2417CD | Colrec Surv, Follow-up w/ CTAC site | 1 | 3 |